Average Insider

Where insiders trade, we follow

$UPB
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
E. Rand Sutherland
CEO
52
Employees
$5.31
Current Price
$1.68B
Market Cap
52W Low$5.24
Current$5.310.3% above low, 99.7% below high
52W High$33.68

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00--All Sells
Sells55$27,603.725,028
2 monthsBuys00--All Sells
Sells55$27,603.725,028
3 monthsBuys00--All Sells
Sells55$27,603.725,028
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Sep 16, 2026
GRAY MICHAEL
CFO and COO
Sale853$5.49$4,682.97View Details
Sep 16, 2026
Ambrose Allison
General Counsel
Sale485$5.49$2,662.65View Details
Sep 16, 2026
Deykin Aaron
Chief Medical Officer
Sale895$5.49$4,913.55View Details
Sep 16, 2026
Sutherland Everett Rand
Director
Sale2,095$5.49$11,501.55View Details
Sep 16, 2026
Houghton Adam
Chief Business Officer
Sale700$5.49$3,843.00View Details
10 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Version: v26.10.4